Aspira Women's Health Files 8-K

Ticker: AWHL · Form: 8-K · Filed: Jun 11, 2025 · CIK: 926617

Sentiment: neutral

Topics: corporate-event, filing, financials

TL;DR

Aspira Women's Health filed an 8-K on June 11, 2025, detailing corporate events and financials.

AI Summary

Aspira Women's Health Inc. filed an 8-K on June 11, 2025, reporting other events and financial statements. The filing details the company's corporate structure and historical name changes, including its former names Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems.

Why It Matters

This filing provides an update on corporate events and financial reporting for Aspira Women's Health Inc., which is relevant for investors tracking the company's regulatory compliance and financial status.

Risk Assessment

Risk Level: low — This is a routine 8-K filing primarily containing corporate information and historical data, with no immediate material financial events disclosed.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Aspira Women's Health Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 11, 2025.

When was Aspira Women's Health Inc. incorporated, and in which jurisdiction?

Aspira Women's Health Inc. was incorporated in Delaware.

What are some of the former names of Aspira Women's Health Inc. mentioned in the filing?

The filing mentions former names including Vermillion, Inc., Ciphergen Biosystems Inc, and Abiotic Systems.

What is the Commission File Number for Aspira Women's Health Inc.?

The Commission File Number for Aspira Women's Health Inc. is 001-34810.

What is the business address and phone number for Aspira Women's Health Inc.?

The business address is 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738, and the business phone number is 512-519-0400.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Aspira Women's Health Inc. (AWHL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing